Biocryst Pharmaceuticals Inc.’s filing revealed that its Director LEVIN ALAN G acquired Company’s shares for reported $49996.0 on May 30 ’24. In the deal valued at $6.36 per share,7,861 shares were bought. As a result of this transaction, LEVIN ALAN G now holds 44,951 shares worth roughly $0.29 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ASELAGE STEVE bought 2,500 shares, generating $16,000 in total proceeds. Upon buying the shares at $6.40, the Director now owns 2,500 shares.
Before that, MILANO VINCENT bought 15,000 shares. Biocryst Pharmaceuticals Inc. shares valued at $93,750 were divested by the Director at a price of $6.25 per share. As a result of the transaction, MILANO VINCENT now holds 66,997 shares, worth roughly $0.43 million.
A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid September from “a Sector perform” to “an Outperform”. Jefferies also remained covering BCRX and has increased its forecast on August 04, 2023 with a “Buy” recommendation from previously “Hold” rating. BofA Securities revised its rating on July 13, 2023. It rated BCRX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BCRX
On Friday, Biocryst Pharmaceuticals Inc. [NASDAQ:BCRX] saw its stock fall -1.67% to $6.46. Over the last five days, the stock has gained 2.05%. Biocryst Pharmaceuticals Inc. shares have risen nearly 7.85% since the year began. Nevertheless, the stocks have fallen -21.89% over the past one year. While a 52-week high of $8.96 was reached on 01/10/24, a 52-week low of $4.03 was recorded on 04/25/24. SMA at 50 days reached $5.16, while 200 days put it at $5.82. A total of 3.83 million shares were traded, compared to the trading of 4.17 million shares in the previous session.
Levels Of Support And Resistance For BCRX Stock
The 24-hour chart illustrates a support level at 6.32, which if violated will result in even more drops to 6.18. On the upside, there is a resistance level at 6.71. A further resistance level may holdings at 6.95. The Relative Strength Index (RSI) on the 14-day chart is 62.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.74%. Stochastics %K at 70.85% indicates the stock is a holding.
